|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
EXP |
Corticosterone results in increased expression of A2M mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases activity |
ISO |
Corticosterone results in decreased activity of ABCG2 protein |
CTD |
PMID:15365089 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
EXP |
[Corticosterone co-treated with oleoyl-estrone] affects the expression of ACACA mRNA |
CTD |
PMID:19545626 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acan |
aggrecan |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of ACAN mRNA Mifepristone inhibits the reaction [Corticosterone results in decreased expression of ACAN mRNA] |
CTD |
PMID:29660438 PMID:29966748 PMID:32663519 |
|
NCBI chr 1:132,981,034...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Ace |
angiotensin I converting enzyme |
increases expression decreases methylation multiple interactions |
EXP |
Corticosterone results in increased expression of ACE mRNA Corticosterone results in decreased methylation of ACE promoter Mifepristone inhibits the reaction [Corticosterone results in increased expression of ACE mRNA] |
CTD |
PMID:15755911 PMID:30423288 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
[Corticosterone co-treated with Physostigmine] results in decreased activity of ACHE protein; ACHE protein inhibits the reaction [Paraoxon results in increased abundance of Corticosterone]; Corticosterone inhibits the reaction [Isoflurophate results in decreased activity of ACHE protein]; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased activity of ACHE protein] |
CTD |
PMID:17005312 PMID:28500787 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acly |
ATP citrate lyase |
multiple interactions |
EXP |
[Corticosterone co-treated with oleoyl-estrone] affects the expression of ACLY mRNA |
CTD |
PMID:19545626 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
increases expression |
EXP |
Corticosterone results in increased expression of ACTA1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr19:51,883,713...51,886,725
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
increases expression |
EXP |
Corticosterone results in increased expression of ACTG2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
EXP |
Corticosterone results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases expression |
ISO |
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein Corticosterone results in increased expression of ADIPOQ mRNA |
CTD |
PMID:29782964 PMID:34801515 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
increases expression |
EXP |
Corticosterone results in increased expression of ADM mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions decreases expression |
ISO |
Edaravone inhibits the reaction [Corticosterone results in decreased expression of ADORA1 mRNA] |
CTD |
PMID:31344373 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
EXP |
Corticosterone results in increased expression of ADRB2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Agt |
angiotensinogen |
increases secretion |
ISO |
AGT protein results in increased secretion of Corticosterone |
CTD |
PMID:28235592 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions decreases expression |
EXP |
Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR1A mRNA] Corticosterone results in decreased expression of AGTR1A mRNA |
CTD |
PMID:30423288 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
multiple interactions decreases expression |
EXP |
Mifepristone inhibits the reaction [Corticosterone results in increased expression of AGTR2 mRNA] Corticosterone results in decreased expression of AGTR2 mRNA |
CTD |
PMID:30423288 |
|
NCBI chr X:112,119,673...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
multiple interactions |
ISO |
[AKR1D1 protein co-treated with NADP] results in increased reduction of Corticosterone |
CTD |
PMID:25500266 |
|
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of AKT1 mRNA |
CTD |
PMID:29966748 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh18a1 |
aldehyde dehydrogenase 18 family, member A1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ALDH18A1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:239,375,657...239,407,967
Ensembl chr 1:239,375,669...239,407,890
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions decreases expression |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of ALPL mRNA] |
CTD |
PMID:30423288 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Angptl2 |
angiopoietin-like 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ANGPTL2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
EXP |
Corticosterone results in increased expression of AQP1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Ar |
androgen receptor |
multiple interactions affects binding increases activity |
ISO EXP |
[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; Corticosterone binds to and results in increased activity of AR protein mutant form; Corticosterone inhibits the reaction [Metribolone results in increased activity of AR protein]; Corticosterone inhibits the reaction [Stanozolol binds to and results in increased activity of AR protein] Corticosterone binds to AR protein Corticosterone results in increased activity of AR protein |
CTD |
PMID:11956172 PMID:14565775 PMID:18324785 PMID:21543282 PMID:29162470 PMID:29625166 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of ARRB1 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB1 mRNA] |
CTD |
PMID:19477151 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arrb2 |
arrestin, beta 2 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of ARRB2 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of ARRB2 mRNA] |
CTD |
PMID:19477151 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
EXP |
Corticosterone results in decreased expression of ASNS mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ATP1A3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp6v1g1 |
ATPase H+ transporting V1 subunit G1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ATP6V1G1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:76,961,462...76,967,642
Ensembl chr 5:76,961,499...76,969,463
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
EXP |
Corticosterone results in decreased expression of AURKB mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avp |
arginine vasopressin |
decreases expression |
EXP |
Corticosterone results in decreased expression of AVP mRNA |
CTD |
PMID:32437893 |
|
NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:117,793,457...117,795,425
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions affects expression |
EXP |
Corticosterone results in increased expression of BAX protein Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BAX mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased expression of BAX protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of BAX protein]] |
CTD |
PMID:27988398 PMID:29625166 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression affects expression |
EXP |
Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]]; so-ochim-tang-gamibang affects the reaction [Corticosterone affects the expression of BCL2 mRNA]; Testosterone inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein]] |
CTD |
PMID:27988398 PMID:29625166 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
EXP |
[Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin; BCL2L1 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin]; JUN protein affects the reaction [Corticosterone results in increased expression of BCL2L1 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of BCL2L1 protein] Corticosterone results in increased expression of BCL2L1 mRNA; Corticosterone results in increased expression of BCL2L1 protein |
CTD |
PMID:15755911 PMID:24480152 PMID:26915917 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression multiple interactions affects expression |
ISO EXP |
Corticosterone results in decreased expression of BDNF protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of BDNF protein]] Corticosterone results in decreased expression of BDNF mRNA O-1602 compound affects the reaction [Corticosterone affects the expression of BDNF protein]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in decreased expression of BDNF mRNA] |
CTD |
PMID:22244747 PMID:22850435 PMID:27988398 PMID:32733244 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bex1 |
brain expressed X-linked 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of BEX1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of BGLAP mRNA Enalapril inhibits the reaction [Corticosterone results in decreased expression of BGLAP mRNA] |
CTD |
PMID:30423288 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
increases expression |
EXP |
Corticosterone results in increased expression of BMP2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
EXP |
Corticosterone results in increased expression of BMP6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:26,318,121...26,469,034
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
EXP |
Corticosterone results in increased expression of BTG2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
C3 |
complement C3 |
affects expression |
EXP |
Corticosterone affects the expression of C3 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
increases abundance multiple interactions increases expression |
EXP |
CALCA protein results in increased abundance of Corticosterone O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CALCA protein] |
CTD |
PMID:12639925 PMID:32733244 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CAPN6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Cars1 |
cysteinyl-tRNA synthetase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CARS mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:198,753,689...198,796,016
Ensembl chr 1:198,753,691...198,795,941
|
|
G |
Cartpt |
CART prepropeptide |
increases abundance multiple interactions |
EXP |
CARTPT protein results in increased abundance of Corticosterone astressin B inhibits the reaction [CARTPT protein results in increased abundance of Corticosterone] |
CTD |
PMID:15271883 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp12 |
caspase 12 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CASP12 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases expression |
EXP |
Corticosterone inhibits the reaction [Deoxyglucose results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Corticosterone inhibits the reaction [Palmitates results in increased activity of CASP3 protein]; Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]]; Mifepristone inhibits the reaction [Corticosterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; so-ochim-tang-gamibang inhibits the reaction [Corticosterone results in increased expression of CASP3 mRNA]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP3 protein]] |
CTD |
PMID:15755911 PMID:26915917 PMID:27988398 PMID:29625166 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CASP4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage |
EXP |
Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased cleavage of CASP8 protein]] |
CTD |
PMID:29625166 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
ISO |
Corticosterone results in increased activity of CAT protein Clozapine inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Clozapine inhibits the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]]; Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]; Sulpiride promotes the reaction [Lipopolysaccharides inhibits the reaction [Corticosterone results in increased activity of CAT protein]] |
CTD |
PMID:14730115 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
EXP ISO |
Corticosterone results in decreased expression of CCL2 mRNA Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA] [Corticosterone co-treated with Isoflurophate] results in increased expression of CCL2 mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of CCL2 mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of CCL2 mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of CCL2 mRNA]; Physostigmine inhibits the reaction [Corticosterone results in decreased expression of CCL2 mRNA] |
CTD |
PMID:15755911 PMID:28500787 PMID:28782715 PMID:29751049 PMID:29846716 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
EXP |
Corticosterone results in increased expression of CCN3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CCNB1 mRNA; Corticosterone results in decreased expression of CCNB1 protein |
CTD |
PMID:15755911 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CCND1 protein |
CTD |
PMID:12807724 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CCND2 mRNA; Corticosterone results in decreased expression of CCND2 protein |
CTD |
PMID:15755911 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CCNE1 protein |
CTD |
PMID:12807724 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cd200 |
Cd200 molecule |
decreases expression |
EXP |
Corticosterone results in decreased expression of CD200 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr11:55,410,166...55,437,527
Ensembl chr11:55,410,196...55,501,648
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
EXP |
Corticosterone results in increased expression of CD36 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd59b |
CD59b molecule |
increases expression |
EXP |
Corticosterone results in increased expression of CD59 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CDC20 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
[Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein |
CTD |
PMID:21655274 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CDK1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases activity decreases expression |
EXP |
Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein] Corticosterone results in decreased activity of CDK2 protein Corticosterone results in decreased expression of CDK2 protein |
CTD |
PMID:12807724 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions decreases expression decreases activity |
EXP |
Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] Corticosterone results in decreased expression of CDK4 protein Corticosterone results in decreased activity of CDK4 protein |
CTD |
PMID:12807724 |
|
NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
affects expression multiple interactions |
EXP |
Corticosterone affects the expression of CDKN1A protein Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein]; Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein] |
CTD |
PMID:12807724 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions increases expression |
EXP |
Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] Corticosterone results in increased expression of CDKN1B protein |
CTD |
PMID:12807724 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
decreases expression |
EXP |
Corticosterone results in decreased expression of CDKN2A mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
increases expression |
EXP |
Corticosterone results in increased expression of CDO1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr18:39,432,473...39,447,253
Ensembl chr18:39,432,474...39,447,296
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
increases expression |
EXP |
Corticosterone results in increased expression of CEACAM10 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
EXP |
Corticosterone results in increased expression of CEBPA mRNA |
CTD |
PMID:30423288 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of CEBPB mRNA CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter] |
CTD |
PMID:15755911 PMID:18650268 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression |
EXP ISO |
Corticosterone results in increased expression of CEBPD mRNA |
CTD |
PMID:15755911 PMID:34801515 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cfd |
complement factor D |
decreases expression |
ISO |
Corticosterone results in decreased expression of CFD mRNA; Corticosterone results in decreased expression of CFD protein |
CTD |
PMID:2912985 |
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CKS2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CLDN2 protein |
CTD |
PMID:29751049 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
increases abundance |
ISO |
CNR1 gene mutant form results in increased abundance of Corticosterone |
CTD |
PMID:15081793 |
|
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of COL2A1 mRNA; Corticosterone results in decreased expression of COL2A1 protein Mifepristone inhibits the reaction [Corticosterone results in decreased expression of COL2A1 mRNA] |
CTD |
PMID:29660438 PMID:29966748 PMID:32663519 |
|
NCBI chr 7:129,098,489...129,127,620
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions decreases expression |
ISO |
Edaravone inhibits the reaction [Corticosterone results in decreased expression of COMT mRNA] |
CTD |
PMID:31344373 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cp |
ceruloplasmin |
increases expression |
EXP |
Corticosterone results in increased expression of CP mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
EXP |
Corticosterone results in increased expression of CPT1A mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases phosphorylation |
ISO |
Corticosterone results in decreased phosphorylation of CREB1 protein |
CTD |
PMID:22850435 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions decreases expression |
ISO |
2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in decreased expression of CREBBP protein]] |
CTD |
PMID:22850435 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions decreases expression increases expression affects expression increases abundance |
EXP ISO |
Astemizole inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; Corticosterone affects the reaction [Nitroprusside results in increased secretion of CRH protein]; Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]; E 4031 inhibits the reaction [Corticosterone inhibits the reaction [CRH protein results in increased secretion of Adrenocorticotropic Hormone]]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of CRH protein] CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone] Corticosterone results in decreased expression of CRH mRNA Corticosterone results in increased expression of CRH mRNA; Corticosterone results in increased expression of CRH protein Corticosterone affects the expression of CRH mRNA CRH protein results in increased abundance of Corticosterone |
CTD |
PMID:3015567 PMID:7816204 PMID:18835572 PMID:21359208 PMID:26821211 PMID:32437893 PMID:32733244 PMID:32780722 More...
|
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of CRHR1 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr10:89,040,203...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
increases expression |
EXP |
Corticosterone results in increased expression of CRISPLD2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
|
|
G |
Cs |
citrate synthase |
decreases activity |
EXP |
Corticosterone results in decreased activity of CS protein |
CTD |
PMID:22244747 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
EXP |
Corticosterone results in increased expression of CSRP2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases expression |
EXP |
Corticosterone results in increased expression of CSRP3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:98,528,067...98,546,647
Ensembl chr 1:98,528,068...98,546,653
|
|
G |
Ctnna1 |
catenin alpha 1 |
multiple interactions |
ISO |
[Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein |
CTD |
PMID:21655274 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
[Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein |
CTD |
PMID:21655274 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctss |
cathepsin S |
increases expression |
EXP |
Corticosterone results in increased expression of CTSS mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:183,089,192...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
increases chemical synthesis |
ISO |
CYP11B1 protein results in increased chemical synthesis of Corticosterone |
CTD |
PMID:16054388 |
|
NCBI chr 7:106,838,590...106,845,004
Ensembl chr 7:106,838,590...106,845,004
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
affects metabolic processing multiple interactions increases hydroxylation increases chemical synthesis |
ISO |
CYP11B2 protein affects the metabolism of Corticosterone [CYP11B2 protein results in increased hydroxylation of Corticosterone] which results in increased chemical synthesis of Aldosterone; [CYP11B2 protein results in increased hydroxylation of Desoxycorticosterone] which results in increased chemical synthesis of Corticosterone CYP11B2 protein results in increased chemical synthesis of Corticosterone |
CTD |
PMID:16054388 PMID:21384875 |
|
NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression |
EXP ISO |
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP1A2 mRNA] Corticosterone results in increased expression of CYP1A2 mRNA |
CTD |
PMID:35301062 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
increases expression |
EXP |
Corticosterone results in increased expression of CYP2A2 mRNA |
CTD |
PMID:35301062 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of CYP2B1 mRNA; Corticosterone results in increased expression of CYP2B1 protein Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B1 protein] |
CTD |
PMID:35301062 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2B6 mRNA] Corticosterone results in increased expression of CYP2B6 mRNA; Corticosterone results in increased expression of CYP2B6 protein |
CTD |
PMID:35301062 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
increases expression |
EXP |
Corticosterone results in increased expression of CYP2C11 mRNA |
CTD |
PMID:35301062 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
increases expression |
EXP |
Corticosterone results in increased expression of CYP2D2 mRNA |
CTD |
PMID:35301062 |
|
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases expression multiple interactions |
EXP ISO |
Corticosterone results in increased expression of CYP2D4 mRNA Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2D6 mRNA] Corticosterone results in increased expression of CYP2D6 mRNA |
CTD |
PMID:15755911 PMID:35301062 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression multiple interactions |
ISO EXP |
Corticosterone results in increased expression of CYP2E1 mRNA; Corticosterone results in increased expression of CYP2E1 protein Corticosterone promotes the reaction [Ethanol results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:35301062 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions increases expression |
ISO |
[Corticosterone binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]]; Ketoconazole inhibits the reaction [Corticosterone results in increased expression of CYP3A4 mRNA] Corticosterone results in increased expression of CYP3A4 mRNA; Corticosterone results in increased expression of CYP3A4 protein |
CTD |
PMID:11581012 PMID:12072427 PMID:12851153 PMID:35301062 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
multiple interactions increases expression |
EXP |
Corticosterone promotes the reaction [Ethanol results in increased expression of CYP3A23-3A1 mRNA] Corticosterone results in increased expression of CYP3A23-3A1 mRNA; Corticosterone results in increased expression of CYP3A23-3A1 protein |
CTD |
PMID:35301062 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Dbi |
diazepam binding inhibitor |
increases expression |
ISO |
Corticosterone results in increased expression of DBI mRNA |
CTD |
PMID:16963002 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
increases expression |
EXP |
Corticosterone results in increased expression of DCXR mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:106,006,404...106,008,294
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of DDIT3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddt |
D-dopachrome tautomerase |
increases expression |
EXP |
Corticosterone results in increased expression of DDT mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
increases expression multiple interactions |
ISO |
Corticosterone results in increased expression of DKK1 protein Mifepristone inhibits the reaction [Corticosterone results in increased expression of DKK1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein] |
CTD |
PMID:21304589 |
|
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of DLG4 protein Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein] |
CTD |
PMID:33872575 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
decreases expression |
EXP |
Corticosterone results in decreased expression of DNMT3A mRNA |
CTD |
PMID:30423288 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dpep1 |
dipeptidase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of DPEP1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Dpt |
dermatopontin |
decreases expression |
EXP |
Corticosterone results in decreased expression of DPT mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:77,122,926...77,151,646
Ensembl chr13:77,123,115...77,151,639
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
multiple interactions |
ISO |
[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone; CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]; Dexamethasone affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone] |
CTD |
PMID:32780722 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Ecrg4 |
ECRG4 augurin precursor |
decreases expression |
EXP |
Corticosterone results in decreased expression of ECRG4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595
|
|
G |
Edn1 |
endothelin 1 |
increases secretion |
EXP |
EDN1 results in increased secretion of Corticosterone |
CTD |
PMID:1659878 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Edn2 |
endothelin 2 |
increases secretion |
EXP |
EDN2 results in increased secretion of Corticosterone |
CTD |
PMID:1659878 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Edn3 |
endothelin 3 |
increases secretion |
EXP |
EDN3 results in increased secretion of Corticosterone |
CTD |
PMID:1659878 |
|
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
increases expression |
EXP |
Corticosterone results in increased expression of EEF2K mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:175,393,119...175,454,452
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
EXP |
Corticosterone results in increased expression of EFEMP1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
Corticosterone results in increased expression of EGLN3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [ESR1 protein binds to TRAF6 protein] |
CTD |
PMID:29625166 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
decreases expression |
EXP |
Corticosterone results in decreased expression of EZH2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Faah |
fatty acid amide hydrolase |
increases activity multiple interactions |
EXP |
Corticosterone results in increased activity of FAAH protein antalarmin inhibits the reaction [Corticosterone results in increased activity of FAAH protein] |
CTD |
PMID:26821211 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of FABP3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] |
CTD |
PMID:29782964 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
affects expression |
EXP |
Corticosterone affects the expression of FABP7 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
EXP |
[Corticosterone co-treated with oleoyl-estrone] affects the expression of FASN mRNA |
CTD |
PMID:19545626 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbln2 |
fibulin 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of FBLN2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
EXP |
Corticosterone results in increased expression of FBN2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr18:51,499,737...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of FKBP5 mRNA Edaravone inhibits the reaction [Corticosterone results in decreased expression of FKBP5 mRNA] |
CTD |
PMID:31344373 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of FLT1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of FMO1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Corticosterone results in increased expression of FOS protein |
CTD |
PMID:28186389 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxs1 |
forkhead box S1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of FOXS1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:141,397,012...141,398,281
Ensembl chr 3:141,397,016...141,398,281
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
ISO |
Corticosterone results in increased expression of FSHB mRNA |
CTD |
PMID:16675544 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
EXP |
Corticosterone results in increased expression of FSTL3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:9,924,670...9,929,195
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
decreases expression |
EXP |
Corticosterone results in decreased expression of FXYD6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
G6pc2 |
glucose-6-phosphatase catalytic subunit 2 |
increases expression |
ISO |
Corticosterone results in increased expression of G6PC2 mRNA |
CTD |
PMID:27300767 |
|
NCBI chr 3:53,999,821...54,005,539
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
multiple interactions increases expression |
ISO EXP |
GAD1 affects the reaction [2,5-dihydro-2,4,5-trimethylthiazoline results in increased secretion of Corticosterone] Corticosterone results in increased expression of GAD1 mRNA |
CTD |
PMID:21219938 PMID:32437893 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
EXP |
Corticosterone results in increased expression of GAL mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gas6 |
growth arrest specific 6 |
increases expression |
EXP |
Corticosterone results in increased expression of GAS6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gatm |
glycine amidinotransferase |
decreases expression |
EXP |
Corticosterone results in decreased expression of GATM mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of GCNT1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
increases expression |
EXP |
Corticosterone results in increased expression of GJA5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of GLT8D1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
|
|
G |
Glul |
glutamate-ammonia ligase |
increases expression |
EXP |
Corticosterone results in increased expression of GLUL mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of GNAI2 mRNA Fluoxetine inhibits the reaction [Corticosterone results in decreased expression of GNAI2 mRNA] |
CTD |
PMID:19477151 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
EXP |
Corticosterone results in increased expression of GPX3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
increases expression |
ISO |
Corticosterone results in increased expression of GREB1 mRNA |
CTD |
PMID:35307500 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Grem1 |
gremlin 1, DAN family BMP antagonist |
decreases expression |
EXP |
Corticosterone results in decreased expression of GREM1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
decreases expression multiple interactions |
ISO |
Corticosterone results in decreased expression of GRIA1 protein Ketamine inhibits the reaction [Corticosterone results in decreased expression of GRIA1 protein] |
CTD |
PMID:33872575 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
increases expression |
EXP |
Corticosterone results in increased expression of GRK5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
Corticosterone results in increased expression of GSTA3 mRNA; Corticosterone results in increased expression of GSTA3 protein |
CTD |
PMID:15755911 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
EXP |
Corticosterone results in increased expression of GSTM2 mRNA; Corticosterone results in increased expression of GSTM2 protein |
CTD |
PMID:15755911 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Hdac7 |
histone deacetylase 7 |
multiple interactions increases expression |
EXP |
HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in increased expression of HDAC7 protein] Corticosterone results in increased expression of HDAC7 mRNA; Corticosterone results in increased expression of HDAC7 protein |
CTD |
PMID:31306741 |
|
NCBI chr 7:128,923,918...128,962,025
Ensembl chr 7:128,923,920...128,962,072
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein] |
CTD |
PMID:29751049 |
|
NCBI chr12:5,973,062...5,978,565
Ensembl chr12:5,901,586...5,978,565
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of HMGB2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
increases expression |
EXP |
Corticosterone results in increased expression of HMGCS2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
|
|
G |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of HMGN2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:146,192,126...146,195,580
Ensembl chr 5:146,192,126...146,195,521
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Hs3st1 |
heparan sulfate-glucosamine 3-sulfotransferase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of HS3ST1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr14:71,185,826...71,223,263
Ensembl chr14:71,185,682...71,223,248
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases chemical synthesis multiple interactions increases oxidation decreases abundance increases expression |
ISO EXP |
HSD11B1 protein results in increased chemical synthesis of Corticosterone [[trimethyltin chloride results in increased abundance of trimethyltin] which co-treated with Corticosterone] results in increased expression of HSD11B1 mRNA; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mRNA]] HSD11B1 protein results in increased oxidation of Corticosterone HSD11B1 gene mutant form results in decreased abundance of Corticosterone [HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; resveratrol inhibits the reaction [HSD11B1 protein results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone] Corticosterone results in increased expression of HSD11B1 mRNA |
CTD |
PMID:15755911 PMID:16751407 PMID:23814014 PMID:25061560 PMID:26859423 PMID:30993381 More...
|
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions increases oxidation increases metabolic processing affects metabolic processing |
EXP ISO |
[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Betamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Dexamethasone inhibits the reaction [HSD11B2 protein affects the metabolism of Corticosterone]; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone]; Ziram inhibits the reaction [HSD11B2 protein results in increased oxidation of Corticosterone] |
CTD |
PMID:19490994 PMID:22796344 PMID:26859423 PMID:32243540 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
EXP |
Corticosterone results in increased expression of HSPB1 mRNA; Corticosterone results in increased expression of HSPB1 protein |
CTD |
PMID:15755911 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb6 |
heat shock protein family B (small) member 6 |
increases expression |
EXP |
Corticosterone results in increased expression of HSPB6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:85,806,898...85,809,072
Ensembl chr 1:85,806,146...85,809,071
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions increases secretion increases expression |
EXP |
[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone]; [Ketanserin binds to and results in decreased activity of HTR2A protein] inhibits the reaction [Methamphetamine results in increased secretion of Corticosterone] Corticosterone results in increased expression of HTR2A mRNA |
CTD |
PMID:15755911 PMID:18363858 PMID:19304867 PMID:19879056 |
|
NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Ier3 |
immediate early response 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of IER3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression multiple interactions increases expression |
EXP |
Corticosterone results in decreased expression of IGF1 mRNA; Corticosterone results in decreased expression of IGF1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of IGF1 mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein] Corticosterone results in increased expression of IGF1 mRNA |
CTD |
PMID:12807724 PMID:15755911 PMID:29343424 PMID:29966748 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of IGF1R mRNA; Corticosterone results in decreased expression of IGF1R protein [IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]] |
CTD |
PMID:12807724 PMID:24667322 PMID:29966748 |
|
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
EXP |
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein] |
CTD |
PMID:24667322 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
multiple interactions |
EXP |
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]] |
CTD |
PMID:24667322 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
decreases expression |
EXP |
Corticosterone results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
increases expression |
EXP |
Corticosterone results in increased expression of IGFBP6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Il15 |
interleukin 15 |
increases expression |
EXP |
Corticosterone results in increased expression of IL15 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr19:25,640,013...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il1b |
interleukin 1 beta |
increases chemical synthesis increases expression affects expression multiple interactions increases secretion |
ISO EXP |
IL1B protein results in increased chemical synthesis of Corticosterone Corticosterone results in increased expression of IL1B mRNA Corticosterone affects the expression of IL1B mRNA Corticosterone results in increased expression of IL1B mRNA; Corticosterone results in increased expression of IL1B protein [Corticosterone co-treated with Isoflurophate] results in increased expression of IL1B mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of IL1B mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate affects the reaction [Corticosterone affects the expression of IL1B mRNA]; Physostigmine affects the reaction [Corticosterone affects the expression of IL1B mRNA] Corticosterone promotes the reaction [Isoflurophate results in increased expression of IL1B mRNA]; Ketorolac inhibits the reaction [IL1B protein results in increased secretion of Corticosterone]; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of IL1B protein] [Finasteride results in increased susceptibility to IL1B protein] which results in increased secretion of Corticosterone |
CTD |
PMID:10800959 PMID:12773775 PMID:19458216 PMID:28500787 PMID:28782715 PMID:29751049 PMID:29846716 PMID:32733244 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of IL1RL1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression increases expression |
EXP ISO |
Corticosterone inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA] Corticosterone results in decreased expression of IL6 mRNA [Corticosterone co-treated with Physostigmine] results in decreased expression of IL6 mRNA; [Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of IL6 mRNA; Corticosterone inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of IL6 mRNA]; Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]; Isoflurophate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate inhibits the reaction [Corticosterone results in decreased expression of IL6 mRNA]; Spironolactone inhibits the reaction [Corticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA]] Corticosterone results in increased expression of IL6 mRNA |
CTD |
PMID:28500787 PMID:28782715 PMID:29846716 PMID:30993381 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Corticosterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] |
CTD |
PMID:29782964 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Itga1 |
integrin subunit alpha 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ITGA1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:46,646,125...46,812,237
Ensembl chr 2:46,653,193...46,812,238
|
|
G |
Itga8 |
integrin subunit alpha 8 |
increases expression |
EXP |
Corticosterone results in increased expression of ITGA8 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:75,304,004...75,501,510
Ensembl chr17:75,304,008...75,501,510
|
|
G |
Itgb1bp2 |
integrin subunit beta 1 binding protein 2 |
increases expression |
EXP |
Corticosterone results in increased expression of ITGB1BP2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr X:66,572,537...66,577,174
Ensembl chr X:66,572,537...66,577,174
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
EXP |
[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased activity of JAK2 protein] inhibits the reaction [HTR2A protein results in increased secretion of Corticosterone] |
CTD |
PMID:19304867 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
JUN protein affects the reaction [Corticosterone results in increased expression of BCL2L1 mRNA] |
CTD |
PMID:26915917 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
increases expression |
EXP |
Corticosterone results in increased expression of KCNH2 mRNA |
CTD |
PMID:18835572 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
increases expression |
EXP |
Corticosterone results in increased expression of KCNJ5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:30,724,923...30,753,083
Ensembl chr 8:30,724,925...30,753,518
|
|
G |
Kdr |
kinase insert domain receptor |
multiple interactions decreases expression |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; Calcium promotes the reaction [Corticosterone results in decreased expression of KDR protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein] |
CTD |
PMID:21647420 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kif15 |
kinesin family member 15 |
decreases expression |
EXP |
Corticosterone results in decreased expression of KIF15 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
|
|
G |
Kifc1 |
kinesin family member C1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of KIFC1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions decreases expression |
EXP |
HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; HDAC7 protein affects the reaction [Corticosterone results in decreased expression of KLF4 protein]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 mRNA]; KLF4 protein inhibits the reaction [Corticosterone results in decreased expression of NPHS1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 mRNA]; trichostatin A inhibits the reaction [Corticosterone results in decreased expression of KLF4 protein] Corticosterone results in decreased expression of KLF4 mRNA; Corticosterone results in decreased expression of KLF4 protein |
CTD |
PMID:31306741 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klf9 |
KLF transcription factor 9 |
increases expression |
EXP |
Corticosterone results in increased expression of KLF9 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:220,700,108...220,725,029
Ensembl chr 1:220,700,108...220,725,037
|
|
G |
Lep |
leptin |
multiple interactions decreases expression |
ISO |
1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]; 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione inhibits the reaction [1-(3-chlorophenyl)piperazine inhibits the reaction [Corticosterone results in decreased expression of LEP protein]]; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein] |
CTD |
PMID:28186389 PMID:29751049 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
multiple interactions decreases expression |
EXP ISO |
[Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of LIF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of LIF mRNA; [Corticosterone co-treated with Physostigmine] results in decreased expression of LIF mRNA Corticosterone results in decreased expression of LIF mRNA |
CTD |
PMID:28500787 PMID:28782715 PMID:29846716 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lmnb1 |
lamin B1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of LMNB1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lpar1 |
lysophosphatidic acid receptor 1 |
increases expression |
EXP |
Corticosterone results in increased expression of LPAR1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
multiple interactions increases secretion |
ISO |
LRRK2 protein mutant form promotes the reaction [Paraquat results in increased secretion of Corticosterone] LRRK2 protein mutant form results in increased secretion of Corticosterone; LRRK2 protein results in increased secretion of Corticosterone |
CTD |
PMID:31174552 |
|
NCBI chr 7:122,826,712...122,987,711
Ensembl chr 7:122,826,696...122,987,703
|
|
G |
Maged2 |
MAGE family member D2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MAGED2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr X:19,733,593...19,741,769
Ensembl chr X:19,733,597...19,740,477
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
multiple interactions increases phosphorylation |
EXP |
1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased phosphorylation of MAP3K7 protein]] |
CTD |
PMID:29625166 |
|
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation decreases phosphorylation multiple interactions decreases activity |
EXP ISO |
Corticosterone results in increased phosphorylation of MAPK1 protein Corticosterone results in decreased phosphorylation of MAPK1 protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]] Corticosterone results in decreased activity of MAPK1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein]]; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK1 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:19175364 PMID:19733225 PMID:22850435 PMID:29343424 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation decreases phosphorylation multiple interactions decreases activity |
EXP ISO |
Corticosterone results in increased phosphorylation of MAPK3 protein Corticosterone results in decreased phosphorylation of MAPK3 protein 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; KT 5823 inhibits the reaction [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]] Corticosterone results in decreased activity of MAPK3 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein]]; Curcumin inhibits the reaction [Corticosterone results in increased phosphorylation of MAPK3 protein]; IGF1 protein inhibits the reaction [Corticosterone results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:19175364 PMID:19733225 PMID:22850435 PMID:29343424 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mb |
myoglobin |
decreases expression |
EXP |
Corticosterone results in decreased expression of MB mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
|
|
G |
Mc2r |
melanocortin 2 receptor |
multiple interactions increases secretion |
EXP |
MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone] |
CTD |
PMID:18609294 |
|
NCBI chr18:62,001,980...62,015,567
Ensembl chr18:62,004,948...62,015,488
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MCM3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MCM4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MCM6 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MCM7 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
|
|
G |
Me1 |
malic enzyme 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of ME1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
decreases expression |
EXP |
Corticosterone results in decreased expression of MELK mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:58,540,393...58,600,937
Ensembl chr 5:58,540,449...58,600,937
|
|
G |
Mfn1 |
mitofusin 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MFN1 mRNA |
CTD |
PMID:22244747 |
|
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mfn2 |
mitofusin 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MFN2 mRNA |
CTD |
PMID:22244747 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
increases expression |
EXP |
Corticosterone results in increased expression of MGST2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
decreases expression |
EXP |
Corticosterone results in decreased expression of MMP12 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
Corticosterone results in increased expression of MT1A mRNA |
CTD |
PMID:15755911 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
Corticosterone results in decreased phosphorylation of MTOR protein |
CTD |
PMID:21647420 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mustn1 |
musculoskeletal, embryonic nuclear protein 1 |
increases expression |
EXP |
Corticosterone results in increased expression of MUSTN1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr16:6,072,908...6,075,158
Ensembl chr16:6,072,833...6,075,161
|
|
G |
Myh11 |
myosin heavy chain 11 |
increases expression |
EXP |
Corticosterone results in increased expression of MYH11 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459
|
|
G |
Ncapd2 |
non-SMC condensin I complex, subunit D2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of NCAPD2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
|
|
G |
Ncaph2 |
non-SMC condensin II complex, subunit H2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of NCAPH2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:120,422,926...120,439,942
Ensembl chr 7:120,422,956...120,439,938
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:11581012 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncs1 |
neuronal calcium sensor 1 |
increases expression |
ISO |
Corticosterone results in increased expression of NCS1 protein |
CTD |
PMID:21647420 |
|
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:14,523,220...14,568,829
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
multiple interactions increases phosphorylation |
ISO |
[Corticosterone results in increased phosphorylation of NDRG1 protein] promotes the reaction [NDRG1 protein binds to CTNNB1 protein]; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CDH2 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNA1 protein; [Corticosterone results in increased phosphorylation of NDRG1 protein] which results in increased expression of and results in increased localization of CTNNB1 protein [Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein |
CTD |
PMID:21655274 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Ndrg2 |
NDRG family member 2 |
increases expression |
EXP |
Corticosterone results in increased expression of NDRG2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr15:24,600,981...24,609,621
Ensembl chr15:24,600,982...24,609,626
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases expression |
EXP |
Corticosterone results in increased expression of NFKBIA mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of NGF protein O-1602 compound inhibits the reaction [Corticosterone results in decreased expression of NGF protein] |
CTD |
PMID:32733244 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nppa |
natriuretic peptide A |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of NPPA mRNA Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:16533503 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
EXP |
Corticosterone results in decreased expression of NPY mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Corticosterone binds to and results in increased activity of NR1I2 protein; Corticosterone promotes the reaction [[NCOA1 protein binds to NR1I2 protein] which results in increased expression of CYP3A4 mRNA]; Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Ketoconazole inhibits the reaction [Corticosterone promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]] |
CTD |
PMID:11581012 PMID:12072427 PMID:16054614 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO |
Corticosterone binds to and results in increased activity of NR1I3 protein; Corticosterone inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein] |
CTD |
PMID:18832183 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions affects binding increases activity affects abundance decreases expression affects localization increases expression |
ISO EXP |
Corticosterone binds to and results in increased activity of NR3C1 protein Corticosterone binds to NR3C1 protein Corticosterone results in increased activity of NR3C1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Carbamazepine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Chlorpromazine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Clozapine inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Corticosterone inhibits the reaction [KDR protein binds to NR3C1 protein]; Lithium inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; NR3C1 protein promotes the reaction [Corticosterone results in decreased expression of KDR protein]; NR3C1 protein promotes the reaction [Corticosterone results in increased expression of DKK1 protein]; Pregnanolone analog inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; Pregnanolone inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]; pyrazolanthrone inhibits the reaction [Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein]]; Valproic Acid inhibits the reaction [Corticosterone results in increased activity of NR3C1 protein] NR3C1 protein affects the abundance of Corticosterone [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Lead inhibits the reaction [Corticosterone binds to NR3C1 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]] Corticosterone affects the localization of NR3C1 protein Corticosterone results in increased expression of NR3C1 mRNA Corticosterone results in increased expression of NR3C1 mRNA; Corticosterone results in increased expression of NR3C1 protein |
CTD |
PMID:10509797 PMID:11861974 PMID:15249158 PMID:15705660 PMID:16049266 PMID:16581232 PMID:18650268 PMID:21304589 PMID:21647420 PMID:22465009 PMID:25056680 PMID:30423288 PMID:31306741 More...
|
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
affects binding |
ISO |
Corticosterone binds to NR3C2 protein |
CTD |
PMID:16061183 |
|
NCBI chr19:30,715,648...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Ntrk3 |
neurotrophic receptor tyrosine kinase 3 |
increases expression |
EXP |
Corticosterone results in increased expression of NTRK3 mRNA |
CTD |
PMID:18363858 |
|
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] |
CTD |
PMID:29751049 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Omd |
osteomodulin |
increases expression |
EXP |
Corticosterone results in increased expression of OMD mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:15,060,217...15,068,441
Ensembl chr17:15,060,217...15,068,441
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
increases expression |
EXP |
Corticosterone results in increased expression of OPLAH mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
EXP |
Corticosterone results in increased expression of ORM1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Osm |
oncostatin M |
multiple interactions |
EXP ISO |
[Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of OSM mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of OSM mRNA; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of OSM mRNA] |
CTD |
PMID:28500787 PMID:28782715 PMID:29846716 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
P3h1 |
prolyl 3-hydroxylase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of P3H1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:132,841,868...132,856,664
Ensembl chr 5:132,841,928...132,856,659
|
|
G |
Pck2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
decreases expression |
EXP |
Corticosterone results in decreased expression of PCK2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr15:29,027,891...29,036,729
Ensembl chr15:29,027,894...29,037,283
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of PCNA mRNA; Corticosterone results in decreased expression of PCNA protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluoro-5-bromobenzamide inhibits the reaction [IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA]]; IGF1 protein inhibits the reaction [Corticosterone results in decreased expression of PCNA mRNA] |
CTD |
PMID:15755911 PMID:29343424 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde2a |
phosphodiesterase 2A |
increases expression multiple interactions |
ISO EXP |
Corticosterone results in increased expression of PDE2A mRNA; Corticosterone results in increased expression of PDE2A mRNA alternative form; Corticosterone results in increased expression of PDE2A protein Mifepristone inhibits the reaction [Corticosterone results in increased expression of PDE2A protein] |
CTD |
PMID:22850435 |
|
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
[Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein; Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein |
CTD |
PMID:21655274 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdlim5 |
PDZ and LIM domain 5 |
increases expression |
EXP |
Corticosterone results in increased expression of PDLIM5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:230,952,251...231,120,329
Ensembl chr 2:230,952,248...231,120,275
|
|
G |
Pdlim7 |
PDZ and LIM domain 7 |
increases expression |
EXP |
Corticosterone results in increased expression of PDLIM7 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
|
|
G |
Pdyn |
prodynorphin |
multiple interactions |
EXP ISO |
Corticosterone inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of PDYN mRNA] PDYN protein promotes the reaction [Cocaine results in increased abundance of Corticosterone] |
CTD |
PMID:17532787 PMID:18687386 |
|
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Penk |
proenkephalin |
multiple interactions |
EXP |
Corticosterone inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of PENK mRNA] |
CTD |
PMID:18687386 |
|
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
|
|
G |
Pfkl |
phosphofructokinase, liver type |
increases expression |
EXP |
Corticosterone results in increased expression of PFKL mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
|
|
G |
Pfkp |
phosphofructokinase, platelet |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr17:63,729,743...63,794,021
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Pfn2 |
profilin 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PFN2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
|
|
G |
Pim3 |
Pim-3 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
Corticosterone results in increased expression of PIM3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
|
|
G |
Pla1a |
phospholipase A1 member A |
increases expression |
EXP |
Corticosterone results in increased expression of PLA1A mRNA |
CTD |
PMID:15755911 |
|
NCBI chr11:62,320,117...62,357,779
Ensembl chr11:62,320,493...62,357,779
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PLK1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Plk2 |
polo-like kinase 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PLK2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plk4 |
polo-like kinase 4 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PLK4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:123,802,512...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Podxl |
podocalyxin-like |
increases expression |
EXP |
Corticosterone results in increased expression of PODXL mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions increases secretion increases abundance decreases abundance decreases secretion |
EXP ISO |
Bromocriptine inhibits the reaction [POMC protein results in decreased secretion of Corticosterone]; Corticosterone inhibits the reaction [Nitroprusside results in increased secretion of POMC protein]; Cromolyn Sodium inhibits the reaction [POMC results in increased secretion of Corticosterone]; Fulvestrant inhibits the reaction [nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; nonylphenol inhibits the reaction [Nitroprusside inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]]; nonylphenol promotes the reaction [POMC protein modified form results in increased secretion of Corticosterone]; oxophenylarsine inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; pervanadate inhibits the reaction [POMC protein results in increased abundance of Corticosterone]; SB 203580 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone] lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]; resveratrol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of Corticosterone]] POMC protein results in decreased abundance of Corticosterone POMC protein modified form results in increased secretion of Corticosterone; POMC protein results in increased secretion of Corticosterone; POMC results in increased secretion of Corticosterone Corticosterone results in decreased secretion of POMC protein; POMC protein results in decreased secretion of Corticosterone |
CTD |
PMID:1659878 PMID:3015567 PMID:7588239 PMID:10518784 PMID:11132610 PMID:11518849 PMID:12742521 PMID:20837582 PMID:27052214 More...
|
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
multiple interactions |
ISO |
Cocaine promotes the reaction [PPP1R1B protein results in increased abundance of Corticosterone] |
CTD |
PMID:10516482 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
decreases expression |
EXP |
Corticosterone results in decreased expression of PPP2R2B mRNA |
CTD |
PMID:15755911 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
|
|
G |
Prim1 |
DNA primase subunit 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PRIM1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
multiple interactions |
ISO |
[Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone; [PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone; Dexamethasone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone]; Dexamethasone inhibits the reaction [PRKAR1A gene mutant form results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[Androgens deficiency affects the activity of PRKAR1A gene mutant form] which results in increased secretion of Corticosterone]; Dihydrotestosterone inhibits the reaction [[PRKAR1A gene mutant form results in increased susceptibility to Androgens deficiency] which results in increased secretion of Corticosterone] |
CTD |
PMID:29367455 |
|
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione promotes the reaction [Corticosterone results in increased activity of PRKCA protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Corticosterone results in increased activity of PRKCA protein] |
CTD |
PMID:16581232 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
MC2R protein promotes the reaction [PRL protein results in increased secretion of Corticosterone]; PRL protein promotes the reaction [MC2R protein results in increased secretion of Corticosterone] |
CTD |
PMID:18609294 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Pten |
phosphatase and tensin homolog |
increases phosphorylation |
ISO |
Corticosterone results in increased phosphorylation of PTEN protein |
CTD |
PMID:21647420 |
|
NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgds |
prostaglandin D2 synthase |
increases expression |
EXP |
Corticosterone results in increased expression of PTGDS mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of PTGS1 mRNA; Corticosterone results in increased expression of PTGS1 protein |
CTD |
PMID:15755911 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
[Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 protein]; Corticosterone promotes the reaction [CEBPB protein binds to PTGS2 promoter]; Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 mRNA]; Dactinomycin inhibits the reaction [Corticosterone results in increased expression of PTGS2 protein]; Mifepristone inhibits the reaction [Corticosterone promotes the reaction [NR3C1 protein binds to PTGS2 promoter]] Corticosterone results in increased expression of PTGS2 mRNA; Corticosterone results in increased expression of PTGS2 protein |
CTD |
PMID:15755911 PMID:18650268 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pth |
parathyroid hormone |
multiple interactions |
EXP |
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; [Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17476578 |
|
NCBI chr 1:167,508,121...167,511,530
Ensembl chr 1:167,508,598...167,511,530
|
|
G |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of PTPN3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
decreases expression |
EXP |
Corticosterone results in decreased expression of PTTG1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Qsox1 |
quiescin sulfhydryl oxidase 1 |
increases expression |
EXP |
Corticosterone results in increased expression of QSOX1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
EXP |
Corticosterone results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rbp1 |
retinol binding protein 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RBP1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
|
|
G |
Reg3b |
regenerating family member 3 beta |
decreases expression |
EXP |
Corticosterone results in decreased expression of REG3B mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Retn |
resistin |
increases expression |
ISO |
Corticosterone results in increased expression of RETN mRNA |
CTD |
PMID:15809511 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Rfc3 |
replication factor C subunit 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RFC3 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
|
|
G |
Rfc4 |
replication factor C subunit 4 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RFC4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
|
|
G |
Rgcc |
regulator of cell cycle |
increases expression |
EXP |
Corticosterone results in increased expression of RGCC mRNA |
CTD |
PMID:15755911 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
RGD1562067 |
similar to cell division cycle associated 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RGD1562067 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 9:46,506,533...46,507,525
Ensembl chr 9:46,506,547...46,507,056
|
|
G |
Rhoj |
ras homolog family member J |
increases expression |
EXP |
Corticosterone results in increased expression of RHOJ mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:94,035,307...94,117,642
Ensembl chr 6:94,035,483...94,118,275
|
|
G |
Rpa2 |
replication protein A2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RPA2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of RRM1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
multiple interactions decreases expression |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of RUNX2 mRNA] |
CTD |
PMID:30423288 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
Corticosterone results in decreased expression of SCD1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sdc1 |
syndecan 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SDC1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
|
|
G |
Sdc2 |
syndecan 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SDC2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sdc4 |
syndecan 4 |
increases expression |
EXP |
Corticosterone results in increased expression of SDC4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
|
|
G |
Selenop |
selenoprotein P |
increases expression |
EXP |
Corticosterone results in increased expression of SELENOP mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
increases expression |
EXP |
Corticosterone results in increased expression of SERPINA3N mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:123,323,632...123,331,166
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression increases phosphorylation multiple interactions |
EXP ISO |
Corticosterone results in increased expression of SGK1 mRNA [Corticosterone results in increased phosphorylation of SGK1 protein] which results in increased phosphorylation of NDRG1 protein [Corticosterone results in increased phosphorylation of and results in increased activity of PDK1 protein] which results in increased phosphorylation of and results in increased activity of SGK1 protein Corticosterone results in increased expression of SGK1 mRNA; Corticosterone results in increased expression of SGK1 protein |
CTD |
PMID:15755911 PMID:21655274 PMID:31520820 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
Corticosterone binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of SLC18A3 protein O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC18A3 protein] |
CTD |
PMID:32733244 |
|
NCBI chr16:7,713,630...7,716,491
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions increases expression |
ISO |
Corticosterone inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC1A2 protein]; Vitamin A promotes the reaction [Corticosterone results in increased expression of SLC1A2 protein] |
CTD |
PMID:17138558 |
|
NCBI chr 3:89,005,129...89,126,498
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
EXP |
Corticosterone inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:9830022 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
decreases activity multiple interactions |
EXP ISO |
Corticosterone results in decreased activity of SLC22A3 protein [Corticosterone results in decreased activity of SLC22A3 protein] inhibits the reaction [Epinephrine results in increased abundance of Epinephrine metabolite]; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased abundance of Epinephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Phenylephrine; [Corticosterone results in decreased activity of SLC22A3 protein] which results in decreased import of Synephrine; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased transport of Histamine]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium] Corticosterone inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of Formoterol Fumarate] |
CTD |
PMID:9830022 PMID:12110607 PMID:12181285 PMID:12411423 PMID:16928864 PMID:17920670 PMID:19053318 PMID:20858707 PMID:21140131 PMID:30189235 More...
|
|
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of SLC22A8 protein O-1602 compound inhibits the reaction [Corticosterone results in increased expression of SLC22A8 protein] |
CTD |
PMID:32733244 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression multiple interactions |
EXP ISO |
Corticosterone results in increased expression of SLC2A1 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] |
CTD |
PMID:15755911 PMID:29751049 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression multiple interactions |
EXP ISO |
Corticosterone results in increased expression of SLC2A4 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA] |
CTD |
PMID:15755911 PMID:29751049 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc6a15 |
solute carrier family 6 member 15 |
multiple interactions decreases expression |
ISO |
Edaravone inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA]; Paroxetine inhibits the reaction [Corticosterone results in decreased expression of SLC6A15 mRNA] |
CTD |
PMID:31344373 |
|
NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239
|
|
G |
Smad2 |
SMAD family member 2 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SMAD2 mRNA; Corticosterone results in decreased expression of SMAD2 protein |
CTD |
PMID:29660438 PMID:32663519 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SMAD3 mRNA |
CTD |
PMID:29660438 PMID:32663519 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smarcd2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
increases expression |
EXP |
Corticosterone results in increased expression of SMARCD2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:91,193,752...91,202,817
Ensembl chr10:91,193,752...91,204,341
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SOD1 mRNA |
CTD |
PMID:22244747 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions decreases activity decreases expression |
EXP |
[IGF2R protein co-treated with IGF1R protein] affects the reaction [IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein]]; IGF2 protein inhibits the reaction [Corticosterone results in decreased expression of SOD2 protein] Corticosterone results in decreased activity of SOD2 protein Corticosterone results in decreased expression of SOD2 mRNA; Corticosterone results in decreased expression of SOD2 protein |
CTD |
PMID:22244747 PMID:24667322 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
increases expression |
EXP |
Corticosterone results in increased expression of SORBS2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SOX4 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
decreases expression |
EXP |
Corticosterone results in decreased expression of SOX9 mRNA; Corticosterone results in decreased expression of SOX9 protein |
CTD |
PMID:29660438 PMID:32663519 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions decreases expression |
EXP |
Enalapril inhibits the reaction [Corticosterone results in decreased expression of SPP1 mRNA] |
CTD |
PMID:30423288 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
EXP ISO |
[Corticosterone co-treated with oleoyl-estrone] affects the expression of SREBF1 mRNA [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA] |
CTD |
PMID:19545626 PMID:29751049 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Corticosterone co-treated with Isoflurophate] results in increased phosphorylation of STAT3 protein; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased phosphorylation of STAT3 protein |
CTD |
PMID:28500787 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of STMN1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases expression |
EXP |
Corticosterone results in increased expression of SULT1A1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Syn1 |
synapsin I |
multiple interactions decreases expression |
ISO |
Ascorbic Acid inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein]; Ketamine inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein] |
CTD |
PMID:33872575 |
|
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
|
|
G |
Synm |
synemin |
increases expression |
EXP |
Corticosterone results in increased expression of SYNM mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:121,333,712...121,363,652
Ensembl chr 1:121,333,720...121,363,652
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
EXP |
[Mirex co-treated with Corticosterone] results in increased activity of TAT protein; Corticosterone promotes the reaction [[NR3C1 protein binds to TAT promoter] which results in increased expression of TAT mRNA] |
CTD |
PMID:2893471 PMID:22465009 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tcf21 |
transcription factor 21 |
increases expression |
EXP |
Corticosterone results in increased expression of TCF21 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:22,701,353...22,704,212
Ensembl chr 1:22,701,353...22,704,202
|
|
G |
Tcp1 |
t-complex 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of TCP1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:47,829,061...47,836,809
Ensembl chr 1:47,828,652...47,836,839
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
increases activity |
EXP |
Corticosterone results in increased activity of TDO2 protein |
CTD |
PMID:7306070 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tf |
transferrin |
increases expression |
EXP |
Corticosterone results in increased expression of TF mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
EXP |
Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein] Corticosterone results in decreased expression of TGFB1 mRNA |
CTD |
PMID:16598785 PMID:29660438 PMID:32663519 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
decreases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of TGFBR1 mRNA; Corticosterone results in decreased expression of TGFBR1 protein Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TGFBR1 mRNA] |
CTD |
PMID:29660438 PMID:32663519 |
|
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgm2 |
transglutaminase 2 |
increases expression |
EXP |
Corticosterone results in increased expression of TGM2 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Th |
tyrosine hydroxylase |
increases expression |
ISO |
Corticosterone results in increased expression of TH protein |
CTD |
PMID:28186389 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
increases expression |
EXP |
Corticosterone results in increased expression of TINAGL1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
|
|
G |
Tk1 |
thymidine kinase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of TK1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] |
CTD |
PMID:29751049 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr5 |
toll-like receptor 5 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] |
CTD |
PMID:29751049 |
|
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
G |
Tnc |
tenascin C |
decreases expression |
EXP |
Corticosterone results in decreased expression of TNC mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
[Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; [Corticosterone co-treated with O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate] results in increased expression of TNF mRNA; [Corticosterone co-treated with Physostigmine] results in increased expression of TNF mRNA; [Corticosterone co-treated with Pyridostigmine Bromide] results in increased expression of TNF mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [Isoflurophate results in increased expression of TNF mRNA]; Corticosterone promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of TNF mRNA] Corticosterone results in increased expression of TNF protein Corticosterone results in increased expression of TNF mRNA [Corticosterone co-treated with Isoflurophate] results in increased expression of TNF mRNA; O-1602 compound inhibits the reaction [Corticosterone results in increased expression of TNF protein] |
CTD |
PMID:28500787 PMID:28782715 PMID:29751049 PMID:29846716 PMID:32733244 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
decreases expression increases expression multiple interactions |
EXP |
Corticosterone results in decreased expression of TNFRSF11B mRNA Corticosterone results in increased expression of TNFRSF11B mRNA [Corticosterone co-treated with PTH protein] results in decreased expression of TNFRSF11B mRNA; Mifepristone inhibits the reaction [Corticosterone results in increased expression of TNFRSF11B mRNA] |
CTD |
PMID:17476578 PMID:29981921 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions decreases expression increases expression |
EXP |
[Corticosterone co-treated with PTH protein] results in decreased expression of TNFSF11 mRNA; Mifepristone inhibits the reaction [Corticosterone results in decreased expression of TNFSF11 mRNA] Corticosterone results in increased expression of TNFSF11 mRNA |
CTD |
PMID:17476578 PMID:29981921 |
|
NCBI chr15:53,674,990...53,705,171
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases expression |
EXP |
Corticosterone results in decreased expression of TOP2A mRNA |
CTD |
PMID:15755911 |
|
NCBI chr10:83,946,186...83,975,694
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tpbg |
trophoblast glycoprotein |
decreases expression |
EXP |
Corticosterone results in decreased expression of TPBG mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 8:86,793,953...86,797,324
Ensembl chr 8:86,793,749...86,797,741
|
|
G |
Tpd52l1 |
TPD52 like 1 |
increases expression |
EXP |
Corticosterone results in increased expression of TPD52L1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
multiple interactions |
ISO EXP |
[Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [AR protein binds to TRAF6 protein]; [Testosterone co-treated with Estradiol co-treated with Corticosterone] promotes the reaction [ESR1 protein binds to TRAF6 protein] 1,3-bis(4-hydroxyphenyl)-4-methyl-5-(4-(2-piperidinylethoxy)phenol)-1H-pyrazole inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein; Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]; Estradiol promotes the reaction [Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]]; Flutamide inhibits the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of TRAF6 protein]]; Testosterone inhibits the reaction [Corticosterone results in increased ubiquitination of TRAF6 protein]; Testosterone promotes the reaction [Estradiol inhibits the reaction [Corticosterone results in increased expression of and results in increased ubiquitination of TRAF6 protein]] |
CTD |
PMID:29625166 |
|
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Trhr |
thyrotropin releasing hormone receptor |
increases expression |
EXP |
Corticosterone results in increased expression of TRHR mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:75,348,672...75,393,310
Ensembl chr 7:75,348,672...75,393,309
|
|
G |
Trim54 |
tripartite motif-containing 54 |
increases expression |
EXP |
Corticosterone results in increased expression of TRIM54 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:25,239,340...25,258,511
Ensembl chr 6:25,239,340...25,258,511
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
increases expression multiple interactions |
EXP |
Corticosterone results in increased expression of TSC22D3 mRNA; Corticosterone results in increased expression of TSC22D3 protein TSC22D3 protein affects the reaction [Corticosterone results in decreased susceptibility to Doxorubicin] |
CTD |
PMID:24480152 PMID:31520820 |
|
NCBI chr X:104,217,898...104,277,935
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Tspo |
translocator protein |
increases expression |
EXP |
Corticosterone results in increased expression of TSPO mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
decreases expression |
EXP |
Corticosterone results in decreased expression of TUBB5 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
decreases expression |
EXP |
Corticosterone results in decreased expression of UBE2C mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Vcan |
versican |
decreases expression |
EXP |
Corticosterone results in decreased expression of VCAN mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression affects expression |
EXP ISO |
Corticosterone inhibits the reaction [TGFB1 protein results in increased secretion of VEGFA protein] Corticosterone results in increased expression of VEGFA protein Corticosterone affects the expression of VEGFA protein |
CTD |
PMID:16598785 PMID:21647420 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wars1 |
tryptophanyl-tRNA synthetase 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of WARS1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 6:127,776,088...127,807,273
Ensembl chr 6:127,776,090...127,807,269
|
|
G |
Wt1 |
WT1 transcription factor |
decreases expression |
EXP |
Corticosterone results in decreased expression of WT1 mRNA; Corticosterone results in decreased expression of WT1 protein |
CTD |
PMID:31306741 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Xpo1 |
exportin 1 |
decreases expression |
EXP |
Corticosterone results in decreased expression of XPO1 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr14:97,233,263...97,275,536
Ensembl chr14:97,233,270...97,275,498
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression |
EXP |
Corticosterone results in increased expression of ZFP36 mRNA |
CTD |
PMID:15755911 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
increases metabolic processing affects response to substance multiple interactions affects abundance increases reduction |
ISO EXP |
HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone HSD11B1 gene affects the susceptibility to 11-dehydrocorticosterone [HSD11B1 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone; Resveratrol inhibits the reaction [HSD11B1 protein results in increased metabolism of 11-dehydrocorticosterone]; Ziram inhibits the reaction [[HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] which results in increased chemical synthesis of Corticosterone]; Ziram inhibits the reaction [HSD11B1 protein results in increased reduction of 11-dehydrocorticosterone] HSD11B1 gene mutant form affects the abundance of 11-dehydrocorticosterone |
CTD |
PMID:16751407 PMID:23814014 PMID:25061560 PMID:26859423 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[HSD11B2 protein results in increased metabolism of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; [HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone; Ziram inhibits the reaction [[HSD11B2 protein results in increased oxidation of Corticosterone] which results in increased chemical synthesis of 11-dehydrocorticosterone] |
CTD |
PMID:26859423 PMID:32243540 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
11-dehydrocorticosterone results in increased expression of IL6 mRNA 11-dehydrocorticosterone promotes the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of IL6 mRNA] |
CTD |
PMID:30993381 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions increases expression |
EXP |
Carbenoxolone inhibits the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [11-dehydrocorticosterone results in increased expression of SGK1 mRNA] |
CTD |
PMID:16533503 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|